ENJOYOR(300020)

Search documents
*ST银江(300020) - 监事会决议公告
2025-04-28 19:12
一、审议通过《关于 2024 年度监事会工作报告的议案》 公司监事会制定了 2024 年工作报告,具体内容详见 2025 年 4 月 29 日中国 证监会指定创业板信息披露网站。 本议案尚需提交公司股东大会审议。 证券代码:300020 证券简称:*ST银江 公告编号:2025-040 银江技术股份有限公司 第六届监事会第十八次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 银江技术股份有限公司(以下简称"公司")第六届监事会第十八次会议于 2025 年 4 月 28 日在公司会议室以现场表决方式召开,会议通知于 2025 年 4 月 21 日以直接送达或传真方式送达。会议应参与表决监事 3 名,实际参与表决监 事 3 名,董事会长列席了会议。本次会议的召开与表决程序符合《中华人民共 和国公司法》和《公司章程》等有关规定。 会议由监事会主席徐佳女士主持,经与会监事讨论,会议决议如下: 本项表决结果:本议案以 3 票同意、0 票反对、0 票弃权获得通过。 二、审议通过《关于 2024 年年度报告全文及其摘要的议案》 《2024 年年度报告》及《20 ...
*ST银江(300020) - 第六届董事会第五次独立董事专门会议决议
2025-04-28 19:11
银江技术股份有限公司 第六届董事会第五次独立董事专门会议决议 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理 准则》《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》、 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 及公司章程等相关规定,银江技术股份有限公司第六届董事会第五次独立董事专 门会议于 2025 年 4 月 28 日以现场表决方式召开,会议通知已于 2025 年 4 月 21 日以直接送达或电话方式送达。本次会议应参与表决独立董事 3 名,实际参与表 决独立董事 3 名。本次会议由独立董事蒋贤品先生召集并主持。 经全体独立董事表决,会议决议如下: 1、审议通过了《关于 2024 年度拟不进行利润分配的议案》 由于 2024 年公司业绩亏损,可供分配利润为负,且在综合分析公司经营情 况、外部经济环境、公司 2025 年经营计划和资金需求等因素的基础上,为保障 公司日常经营发展,增强公司抵御风险的能力,公司拟定 2024 年度利润分配预 案为:公司 2024 年度拟不派发现金红利,不送红股,不进行资本公积金转增股 本。本年度利润分配预案从公 ...
*ST银江(300020) - 董事会决议公告
2025-04-28 19:11
会议由董事长王腾先生主持,经与会董事讨论,形成如下决议: 一、审议通过《关于 2024 年度总经理工作报告的议案》 本项表决结果:本议案以 9 票同意、0 票反对、0 票弃权获得通过。 证券代码:300020 证券简称:*ST 银江 公告编号:2025-039 银江技术股份有限公司 第六届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 银江技术股份有限公司(以下简称"公司"或"银江技术")第六届董事会第十 九次会议于 2025 年 4 月 28 日在公司会议室以现场的表决方式召开,会议通知于 2025 年 4 月 21 日以直接送达或电话方式送达。会议应参与表决董事 9 名,实际 参与表决董事 9 名。本次会议的召开和表决程序符合《中华人民共和国公司法》 和《公司章程》等有关规定。 二、审议通过《关于 2024 年度董事会工作报告的议案》 公司独立董事蒋贤品先生、罗吉华先生、刘国平先生向董事会递交了《独立 董事 2024 年度述职报告》,并将在公司 2024 年度股东大会上进行述职。 具体内容详见 2025 年 4 月 29 日中国 ...
*ST银江(300020) - 董事会审计委员会2025年第二次会议决议
2025-04-28 19:11
根据《深圳证券交易所创业板股票上市规则》及《银江技术股份有限公司董 事会审计委员会议事规则》等有关规定,银江技术股份有限公司(以下简称"公 司")董事会审计委员会于 2025 年 4 月 28 日召开了董事会审计委员会 2025 年 第二次会议,认真审议了下列事项: 一、审议通过了《关于 2024 年年度报告全文及其摘要的议案》 银江技术股份有限公司 经审议,审计委员会认为 2024 年年度报告全文及其摘要,客观、真实地反 映了公司的经营情况。 本项表决结果:本议案以 3 同意、0 票反对、0 票弃权获得通过。 二、审议通过了《关于 2024 年度财务决算报告的议案》 董事会审计委员会 2025 年第二次会议决议 本项表决结果:本议案以 3 同意、0 票反对、0 票弃权获得通过。 三、审议通过了《关于 2025 年度财务预算报告的议案》 本项表决结果:本议案以 3 同意、0 票反对、0 票弃权获得通过。 四、审议通过了《关于 2024 年度拟不进行利润分配的议案》 本项表决结果:本议案以 3 同意、0 票反对、0 票弃权获得通过。 五、审议通过了《关于 2024 年度募集资金存放与使用情况的专项报告的议 案》 ...
*ST银江(300020) - 2024年度拟不进行利润分配的公告
2025-04-28 19:10
证券代码:300020 证券简称:*ST 银江 公告编号:2025-038 银江技术股份有限公司 2024 年度拟不进行利润分配的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 银江技术股份有限公司(以下简称"公司"或"银江技术")于 2025 年 4 月 28 日召开第六届董事会第十九次会议及第六届监事会第十八次会议,审议通 过了《关于 2024 年度拟不进行利润分配的议案》,本事项尚需提交公司 2024 年度股东大会审议,现将具体情况公告如下: 一、2024 年度利润分配预案基本情况 2024 年,经中喜会计师事务所(特殊普通合伙)审计,公司 2024 年度合并 报表归属于母公司所有者的净利润-941,488,503.77元,截止2024年12月31日, 公司合并报表中未分配利润为-74,049,524.96 元,母公司未分配利润为 223,710,945.71 元。根据《上市公司自律监管指引第 2 号——创业板上市公司 规范运作》等规定,按照合并报表、母公司报表中可供分配利润孰低的原则,截 至 2024 年 12 月 31 日,公司可供股东分配的净 ...
*ST银江(300020) - 关于申请撤销退市风险警示及部分其他风险警示暨继续被实施其他风险警示的公告
2025-04-28 19:10
证券代码:300020 证券简称:*ST 银江 公告编号:2025-046 银江技术股份有限公司 关于申请撤销退市风险警示及部分其他风险警示 暨继续被实施其他风险警示的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、银江技术股份有限公司(以下简称"公司")于 2025 年 4 月 28 日召开 第六届董事会第十九次会议,审议通过了《关于申请撤销退市风险警示及部分其 他风险警示暨继续被实施其他风险警示的议案》,并于同日向深圳证券交易所(以 下简称"深交所")申请撤销对公司股票交易实施退市风险警示以及部分其他风 险警示,上述申请能否审核批准尚存在不确定性,敬请投资者注意投资风险。 2、公司于 2025 年 4 月 21 日收到中国证券监督管理委员会浙江监管局下发 的《行政处罚决定书》(〔2025〕15 号),根据收到的《行政处罚决定书》认定 的情况,公司触及《上市规则》第 9.4 条规定的其他风险警示情形。截至本公告 披露日,上述其他风险警示情形暂未消除。 3、如本次撤销申请获得深交所批准,公司股票仍将继续被实施其他风险警 示,股票交易日涨跌 ...
*ST银江(300020) - 关于前期会计差错更正的公告及追溯调整的公告
2025-04-28 19:10
证券代码:300020 证券简称:*ST 银江 公告编号:2025-044 银江技术股份有限公司 关于前期会计差错更正及追溯调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: 1、本次前期会计差错更正采用追溯调整法。 2、本次前期会计差错更正不会导致公司已披露的定期报告出现盈亏性质的 改变,不会导致公司触及财务类强制退市指标。 根据《决定书》所认定的情况,公司对相关年度的财务报告数据进行了严格 自查,并针对《决定书》中涉及的事项进行自查整改工作。根据《企业会计准则 第 28 号——会计政策、会计估计变更和差错更正》《公开发行证券的公司信息 披露编报规则第 19 号——财务信息的更正及相关披露》等有关规定和要求,公 司以《决定书》为依据,结合自查情况,并基于谨慎性原则,对上述问题产生的 前期会计差错采用追溯重述法进行更正调整。 二、前期会计差错更正对公司财务状况和经营成果的影响 本公司采用追溯重述法对已披露的定期报告进行更正和调整,不会导致公司 已披露的相关定期报告出现盈亏性质的改变。因会计差错影响财务报表项及金额 如下: 1)对 202 ...
银江技术(300020) - 2025 Q1 - 季度财报
2025-04-28 19:00
Financial Performance - The company's operating revenue for Q1 2025 was ¥60,265,950.83, a decrease of 87.00% compared to ¥463,584,237.18 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥70,381,007.34, representing a decline of 772.16% from a profit of ¥10,470,883.58 in the previous year[5] - Basic and diluted earnings per share were both -¥0.09, a decrease of 1,000.00% from ¥0.01 in the previous year[5] - Total operating revenue for the current period is CNY 60,265,950.83, a significant decrease from CNY 463,584,237.18 in the previous period, representing a decline of approximately 87%[18] - Net profit for the current period is a loss of CNY 70,566,327.49, contrasting with a net profit of CNY 10,234,862.43 in the previous period, marking a shift of over 790%[19] - The total comprehensive income for the period was -70,566,327.49, compared to 10,234,862.43 in the previous period[20] Assets and Equity - Total assets at the end of the reporting period were ¥5,806,021,325.13, down 2.00% from ¥5,924,640,581.55 at the end of the previous year[5] - The company's equity attributable to shareholders decreased by 2.19% to ¥3,150,081,135.33 from ¥3,220,462,142.67 at the end of the previous year[5] - The company's total assets decreased from CNY 5,924,640,581.55 to CNY 5,806,021,325.13, a reduction of approximately 2%[16] - The total equity attributable to shareholders decreased from CNY 3,220,462,142.67 to CNY 3,150,081,135.33, a decrease of approximately 2.2%[16] Cash Flow - Net cash flow from operating activities improved to -¥59,898,476.20, a 62.61% increase compared to -¥160,187,181.20 in the same period last year[5] - Cash inflow from operating activities totaled 154,880,389.45, significantly lower than 569,785,852.99 in the previous period[21] - Cash outflow from operating activities was 214,778,865.65, down from 729,973,034.19 in the previous period[22] - Cash flow from investing activities generated a net inflow of 1,000,000.00, compared to a net outflow of -75,697.00 in the previous period[22] - Cash flow from financing activities resulted in a net outflow of -48,257,567.69, contrasting with a net inflow of 35,280,514.69 in the previous period[22] - The ending cash and cash equivalents balance was 62,082,777.75, down from 562,351,736.45 in the previous period[22] Expenses - Total operating costs for the current period amount to CNY 110,789,704.38, compared to CNY 456,223,790.19 in the previous period, indicating a decrease of about 76%[18] - Research and development expenses for the current period are CNY 6,127,005.01, down from CNY 11,178,922.51 in the previous period, a reduction of about 45%[19] - The company experienced a decrease in sales and management expenses as part of cost-cutting measures[11] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 32,290[10] - The largest shareholder, Yinjian Technology Group, holds 10.30% of the shares, with 81,883,007 shares pledged[10] Impairment and Losses - The company reported a significant increase in credit impairment losses due to reduced project collections[11] - The company reported a significant increase in credit impairment losses of CNY 14,489,964.10 compared to a gain of CNY 1,167,205.84 in the previous period[19] Audit and Future Outlook - The company did not undergo an audit for the first quarter report[24] - Future outlook and strategic initiatives were not detailed in the provided documents, suggesting a potential area for further communication in upcoming reports[16] - The company plans to implement new accounting standards starting in 2025[23]
银江技术(300020) - 2024 Q4 - 年度财报
2025-04-28 19:00
Financial Performance - The company's operating revenue for 2024 was ¥547,905,797.90, a decrease of 53.13% compared to ¥1,169,077,879.62 in 2023[22]. - The net profit attributable to shareholders for 2024 was -¥941,488,503, representing a decline of 298.33% from -¥233,950,957 in 2023[22]. - The net cash flow from operating activities for 2024 was -¥346,905,408, a decrease of 37.94% compared to -¥251,494,322 in 2023[22]. - The basic earnings per share for 2024 was -¥1.18, down 268.75% from -¥0.32 in 2023[22]. - Total assets at the end of 2024 were ¥5,924,640,581.55, a decrease of 14.04% from ¥6,966,180,410.41 at the end of 2023[22]. - The net assets attributable to shareholders at the end of 2024 were ¥3,220,462,141.67, down 22.97% from ¥4,209,446,490.49 at the end of 2023[22]. - The company reported a significant decline in quarterly performance, with Q4 2024 net profit at -¥774,306,811.28[24]. - The company has acknowledged accounting errors leading to restatements of previous financial data due to a regulatory decision[22]. - The company has been under scrutiny for its financial reporting, indicating potential uncertainties in its ongoing operations[22]. Investment and R&D - The company plans to increase investment in artificial intelligence technology research and development, particularly in integrating AI large model technologies with existing products and services[4]. - The company is increasing investment in AI technology application R&D, particularly in integrating AI large model technologies with existing products and services[50]. - The company has established a mature R&D system over nearly 30 years, supported by national-level technology centers and research institutes[51]. - The number of R&D personnel decreased from 249 in 2023 to 144 in 2024, a reduction of 42.17%[71]. - R&D expenditure amounted to approximately ¥82 million in 2024, representing 14.97% of operating revenue, up from 10.56% in 2023[71]. - The proportion of capitalized R&D expenses increased significantly to 65.77% of total R&D expenditure in 2024, compared to 34.31% in 2023[71]. Corporate Governance - The company has a performance assessment management method in place to determine the remuneration of directors and senior management[126]. - The company maintains independence from its controlling shareholder in terms of assets, personnel, finance, and operations, ensuring a complete business system[112]. - The company has an independent financial department and decision-making system, ensuring financial independence and compliance with tax regulations[113]. - The company respects the rights of stakeholders and actively communicates with them to balance interests and promote sustainable development[111]. - The board of directors consists of 9 members, including 3 independent directors, and has held 6 meetings during the reporting period[109]. - The company has established a risk internal control management organization comprising the audit committee and internal audit department[143]. - The company has committed to strict adherence to legal and regulatory requirements in its operations and disclosures[158]. Market and Strategic Focus - The company aims to enhance its market share in transportation, health, and education sectors, leveraging the opportunities presented by the "Digital China" initiative[96]. - In 2025, the company plans to focus on core business areas and strengthen its product competitiveness, particularly in first-tier cities and high-value clients[97]. - The company will increase investment in core products and solutions, particularly in the "Yinjiang City Brain" series, to enhance its service offerings[98]. - The company is actively pursuing mergers and acquisitions to enhance its competitive position and expand its service offerings[119][123]. - The strategic focus includes improving operational efficiency and customer satisfaction to drive long-term profitability[119][120]. Legal and Compliance Issues - The company has received an administrative penalty from the China Securities Regulatory Commission, with fines totaling 2.5 million RMB for various individuals, including 100,000 RMB for Cheng Ping[127]. - The company has faced administrative penalties from the China Securities Regulatory Commission for failing to disclose information in a timely manner, with public reprimands issued for multiple executives[180]. - The company has reported a significant increase in non-operating fund occupation, with cumulative amounts for 2023 and the first half of 2024 being CNY 663.29 million and CNY 434.52 million, respectively[164]. - The audit report issued by Zhongxinghua Accounting Firm for the 2023 financial report was unable to express an opinion due to insufficient evidence regarding significant fund transfers and discrepancies in cost and expense recognition[166]. - The company will enhance training for financial personnel to improve their professional competence[168]. Fund Management and Utilization - The company has a fundraising utilization rate of 100% for the reported period, reflecting effective capital management[86]. - The company has reported a total fund occupation balance of ¥196,954,882.54 as of August 29, 2024, which has been fully repaid by the controlling shareholder by December 30, 2024[149]. - The company is actively working to resolve the freezing of raised funds through negotiations with courts and banks, aiming to restore liquidity[150]. - The company has committed to enhancing internal control measures and conducting special internal audits to improve operational compliance and information disclosure[150]. Employee and Management Changes - The company experienced a management change with the resignation of Wu Mengli, Vice General Manager and Secretary of the Board, due to personal reasons on August 9, 2024[118]. - The current management team includes experienced professionals with backgrounds in engineering, finance, and human resources, contributing to the company's strategic direction[119][120][121][122][123]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to 599.03 million RMB[128]. Technology and Innovation - The company has developed an AI computing center with a designed capacity of 500 PFLOPS to support smart city and government digitalization initiatives[41]. - The company launched a series of large models, including "Yinjiang Tongming Health," "Yinjiang Tongming Wenwen," and "Yinjiang Tongming Zhengwu," aimed at enhancing smart solutions across health management, smart transportation, and government services[42]. - The company is enhancing its product line in big data and AI, focusing on traffic congestion prediction and management through advanced algorithms and models[69]. - The company is building a health big data analysis platform to address data barriers between healthcare institutions, enabling comprehensive patient data access for better decision-making[70]. Risks and Challenges - The company faces policy risks due to its reliance on government clients, which can be affected by macroeconomic conditions and policy changes[100]. - The company is aware of the risks associated with the smart city business model, including potential delays in project funding and execution due to government changes[102]. - The company has acknowledged potential tax liabilities that may arise from the red-chip structure dissolution and is prepared to address them[159].
*ST银江(300020) - 第六届董事会第十七次会议决议公告
2025-04-25 10:40
证券代码:300020 证券简称:*ST 银江 公告编号:2025-026 银江技术股份有限公司 第六届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 银江技术股份有限公司(以下简称"公司"或"银江技术")第六届董事会第十 七次会议于 2025 年 4 月 25 日在公司会议室以现场和通讯相结合的表决方式召开, 会议通知于 2024 年 4 月 18 日以直接送达或电话方式送达。会议应参与表决董事 9 名,实际参与表决董事 9 名。本次会议的召开和表决程序符合《中华人民共和 国公司法》和《公司章程》等有关规定。 会议由董事长王腾先生主持,经与会董事讨论,形成如下决议: 一、 审议通过《关于新增募集资金专项账户的议案》 经审议,董事会认为:本次新增募集资金专项账户,便于公司募集资金结算 与管理,有利于提高募集资金的使用效率,不存在变相改变募集资金用途的情形。 因此,同意增设一个募集资金专项账户,用于募集资金的存储、使用和管理。同 时授权公司管理层具体办理本次开立募集资金专项账户及签署募集资金监管协 议等相关事项事宜,确保尽快与持续督导 ...